Shenzhen Key Laboratory of Gene Regulation and Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
Nat Protoc. 2021 Aug;16(8):4084-4107. doi: 10.1038/s41596-021-00583-5. Epub 2021 Jul 19.
Profiling chromatin accessibility at the single-cell level provides critical information about cell type composition and cell-to-cell variation within a complex tissue. Emerging techniques for the interrogation of chromatin accessibility in individual cells allow investigation of the fundamental mechanisms that lead to the variability of different cells. This protocol describes a fast and robust method for single-cell chromatin accessibility profiling based on the assay for transposase-accessible chromatin using sequencing (ATAC-seq). The method combines up-front bulk Tn5 tagging of chromatin with flow cytometry to isolate single nuclei or cells. Reagents required to generate sequencing libraries are added to the same well in the plate where cells are sorted. The protocol described here generates data of high complexity and excellent signal-to-noise ratio and can be combined with index sorting for in-depth characterization of cell types. The whole experimental procedure can be finished within 1 or 2 d with a throughput of hundreds to thousands of nuclei, and the data can be processed by the provided computational pipeline. The execution of the protocol only requires basic techniques and equipment in a molecular biology laboratory with flow cytometry support.
在单细胞水平上进行染色质可及性分析可以提供关于复杂组织中细胞类型组成和细胞间变异的关键信息。用于单个细胞中染色质可及性检测的新兴技术可以研究导致不同细胞变异的基本机制。本方案描述了一种基于转座酶可及染色质测序(ATAC-seq)的快速、稳健的单细胞染色质可及性分析方法。该方法将批量 Tn5 标记的染色质与流式细胞术相结合,以分离单个核或细胞。用于生成测序文库的试剂添加到细胞分选的同一孔板中。本文描述的方案可生成高复杂度和出色信噪比的数据,并可与索引分选结合使用,以深入表征细胞类型。整个实验过程可在 1 或 2 天内完成,通量为数百至数千个核,数据可通过提供的计算管道进行处理。该方案的执行仅需要分子生物学实验室中的基本技术和设备,并配备流式细胞术支持。
STAR Protoc. 2021-9-17
Nat Commun. 2018-12-17
Brief Bioinform. 2024-7-23
Methods Mol Biol. 2024
Genome Biol. 2021-3-4
J Liq Biopsy. 2024-11-26
Sci China Life Sci. 2024-12-20
Genome Biol Evol. 2024-11-1
Biomark Res. 2024-9-27
Front Oncol. 2024-8-29
Genome Biol. 2019-11-18
Nat Commun. 2019-10-8
Mol Cell. 2019-8-27